XVIVO

Targeting CXCR4 in WHIM Syndrome MOA Animation 

Prev Next
Previous

Thoracic Outlet Syndrome Animation

Next medical animation of CRISPR gene editing is groundbreaking but complex. For Intellia Therapeutics, we created a patient-friendly animated experience to help clinical trial participants understand how CRISPR works- clearly, accurately, and with a sense of warmth and curiosity.

Gene Editing Exploration with CRISPR Animation

X4 Pharmaceuticals wanted to create a 3D medical animation for the launch of their therapeutic XOLREMDITM, indicated for the treatment of WHIM syndrome, a rare immunodeficiency disorder. The main goal was to communicate the complexity of WHIM syndrome and how XOLREMDI cuts through this complexity by targeting the underlying cause of the disease.

Keywords: Animation, 3D, Video, Cell biology / Histology, Molecular Biology, Mechanism of Action (MOA)

XVIVO